Gili Kenet, MD

Director
The National Hemophilia Center, and Amalia Biron Research Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel
Yehud-Monosson, HaMerkaz, Israel

Prof Gili Kenet is pediatric Hematologist, director of the Israeli National Hemophilia Center in Sheba Medical Center, Tel Hashomer, and the head of the Amalia Biron Thrombosis Reserach Institute of Tel Aviv University .
Professor Kenet is the author of over 260 peer reviewed scientific publications, review articles and book chapters. She is an active member of WFH and ISTH, a former Chairperson of the Pediatric and Peri-natal Hemostasis SSC and co- chair of the FVIII/ FIX/ RBD SSC of ISTH.

Presentation(s):

• OC 20.1 - Bleeding, FVIII activity, and safety 3 years after gene transfer with valoctocogene roxaparvovec: Results from GENEr8-1

  Sunday, June 25, 2023
  14:45 – 15:00 ET

• PB0020 - Anticoagulation discharge treatment recommendations in patients admitted with a first-time diagnosis of atrial fibrillation

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0301 - Ocular Vein Occlusion in Pediatrics: Should Thrombophilia Investigation and Anticoagulant Treatment Be Initiated?

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• OC 43.5 - Should immune tolerance be pursued in the era of Emicizumab? Longitudinal follow up of a FVIII inhibitor cohort - Real World Data

  Monday, June 26, 2023
  15:45 – 16:00 ET

• OC 49.1 - 3K3A-Activated Protein C treatment exerts anti-inflammatory and blood barrier stabilizing effects in the retina, and inhibits choroidal neovascularization

  Monday, June 26, 2023
  14:45 – 15:00 ET

• PB0569 - Elevated International Normalized Ratio in Hospitalized Patients Treated with Direct Oral Anticoagulants

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB0627 - Management of invasive procedures in patients with Hemophilia A receiving Emicizumab prophylaxis: Real-world data from a national Hemophilia treatment center.

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB0680 - Clinical characteristics, therapy and outcome of children with Hemophilia B and inhibitors: a PedNet study

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB1390 - Gray platelet syndrome- novel NBEAL2 pathogenic variants and hemostasis evaluation by global coagulation assays.

  Tuesday, June 27, 2023
  18:30 – 19:30 ET